ALNYAlnylam Pharmaceuticals, Inc.

$239.03

Is it safe?

Can ALNY take a bad year?

The deepest fall in ALNY's price history on file is −60%; it is −51% below its high today.

5.44

Altman Z-score · distress below 1.8 · safe above 3 · safe zone, the balance sheet is not what threatens this one

Interest cover
2.18×

Interest cover · operating profit covers the interest bill, with room to spare

Annualised volatility
44%

Annualised volatility · roughly twice as jumpy as the market

Worst drawdown on file
−60%

Worst drawdown on file · −51% today

Details
Cash and short-term investments
$2.91B
EBITDA, trailing twelve months
$557M
Operating profit, trailing twelve months
$502M
Annualised volatilitytwo years of daily moves
44%
Worst drawdown on file
−60%
Below its 52-week high
−51%

Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.